• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强子劫持决定神经母细胞瘤中额外染色体环状 MYCN 扩增子的结构。

Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma.

机构信息

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

RG Development & Disease, Max Planck Institute for Molecular Genetics, Ihnestraße 63-73, 14195, Berlin, Germany.

出版信息

Nat Commun. 2020 Nov 16;11(1):5823. doi: 10.1038/s41467-020-19452-y.

DOI:10.1038/s41467-020-19452-y
PMID:33199677
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7669906/
Abstract

MYCN amplification drives one in six cases of neuroblastoma. The supernumerary gene copies are commonly found on highly rearranged, extrachromosomal circular DNA (ecDNA). The exact amplicon structure has not been described thus far and the functional relevance of its rearrangements is unknown. Here, we analyze the MYCN amplicon structure using short-read and Nanopore sequencing and its chromatin landscape using ChIP-seq, ATAC-seq and Hi-C. This reveals two distinct classes of amplicons which explain the regulatory requirements for MYCN overexpression. The first class always co-amplifies a proximal enhancer driven by the noradrenergic core regulatory circuit (CRC). The second class of MYCN amplicons is characterized by high structural complexity, lacks key local enhancers, and instead contains distal chromosomal fragments harboring CRC-driven enhancers. Thus, ectopic enhancer hijacking can compensate for the loss of local gene regulatory elements and explains a large component of the structural diversity observed in MYCN amplification.

摘要

MYCN 扩增驱动了六分之一的神经母细胞瘤病例。这些额外的基因拷贝通常存在于高度重排的、染色体外的环状 DNA(ecDNA)上。迄今为止,尚未描述确切的扩增子结构,其重排的功能相关性尚不清楚。在这里,我们使用短读长和纳米孔测序分析 MYCN 扩增子结构,并使用 ChIP-seq、ATAC-seq 和 Hi-C 分析其染色质景观。这揭示了两种不同类别的扩增子,它们解释了 MYCN 过表达的调节要求。第一类总是共同扩增由去甲肾上腺素能核心调节回路(CRC)驱动的近端增强子。第二类 MYCN 扩增子的特点是结构高度复杂,缺乏关键的局部增强子,而是包含携带 CRC 驱动增强子的远端染色体片段。因此,异位增强子劫持可以弥补局部基因调控元件的缺失,并解释了在 MYCN 扩增中观察到的结构多样性的很大一部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/d762e863c340/41467_2020_19452_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/f881f2113a2a/41467_2020_19452_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/3cc9a449c239/41467_2020_19452_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/1150795699d0/41467_2020_19452_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/6f2ade128d8a/41467_2020_19452_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/d533bac42c58/41467_2020_19452_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/e951a811db42/41467_2020_19452_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/d762e863c340/41467_2020_19452_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/f881f2113a2a/41467_2020_19452_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/3cc9a449c239/41467_2020_19452_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/1150795699d0/41467_2020_19452_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/6f2ade128d8a/41467_2020_19452_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/d533bac42c58/41467_2020_19452_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/e951a811db42/41467_2020_19452_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa55/7669906/d762e863c340/41467_2020_19452_Fig7_HTML.jpg

相似文献

1
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma.增强子劫持决定神经母细胞瘤中额外染色体环状 MYCN 扩增子的结构。
Nat Commun. 2020 Nov 16;11(1):5823. doi: 10.1038/s41467-020-19452-y.
2
Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification.驱动一部分高危儿童神经母细胞瘤,其激活机制包括增强子劫持和局部增强子扩增。
Cancer Discov. 2018 Mar;8(3):320-335. doi: 10.1158/2159-8290.CD-17-0993. Epub 2017 Dec 28.
3
Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma.增强子入侵塑造神经母细胞瘤中 MYCN 依赖性转录扩增。
Nat Genet. 2018 Apr;50(4):515-523. doi: 10.1038/s41588-018-0044-9. Epub 2018 Jan 29.
4
Epigenomic profiling of neuroblastoma cell lines.神经母细胞瘤细胞系的表观基因组分析。
Sci Data. 2020 Apr 14;7(1):116. doi: 10.1038/s41597-020-0458-y.
5
Functional Enhancers Shape Extrachromosomal Oncogene Amplifications.功能增强子塑造染色体外致癌基因扩增。
Cell. 2019 Nov 27;179(6):1330-1341.e13. doi: 10.1016/j.cell.2019.10.039. Epub 2019 Nov 21.
6
Predicting amplification of using CpG methylation biomarkers in neuroblastoma.利用 CpG 甲基化生物标志物预测神经母细胞瘤的扩增。
Future Oncol. 2021 Dec;17(34):4769-4783. doi: 10.2217/fon-2021-0522. Epub 2021 Nov 9.
7
HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype.HAND2 辅助 MYCN 增强子侵袭以调节去甲肾上腺素能神经母细胞瘤表型。
Cancer Res. 2023 Mar 2;83(5):686-699. doi: 10.1158/0008-5472.CAN-22-2042.
8
Telomerase activation by genomic rearrangements in high-risk neuroblastoma.高危神经母细胞瘤中基因组重排导致的端粒酶激活
Nature. 2015 Oct 29;526(7575):700-4. doi: 10.1038/nature14980. Epub 2015 Oct 14.
9
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.MYCN 通过与转录因子 AP4 建立调控回路来促进神经母细胞瘤的恶性发展。
Oncotarget. 2016 Aug 23;7(34):54937-54951. doi: 10.18632/oncotarget.10709.
10
Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma.口服生物利用度 CDK9/2 抑制剂在 MYCN 驱动的神经母细胞瘤中具有基于机制的治疗潜力。
J Clin Invest. 2020 Nov 2;130(11):5875-5892. doi: 10.1172/JCI134132.

引用本文的文献

1
Extrachromosomal DNA associates with poor survival across a broad spectrum of childhood solid tumors.染色体外DNA与多种儿童实体瘤的不良生存率相关。
medRxiv. 2025 Aug 7:2025.07.22.24308163. doi: 10.1101/2025.07.22.24308163.
2
High-dose DFMO alters protein translation in neuroblastoma.高剂量二氟甲基鸟氨酸改变神经母细胞瘤中的蛋白质翻译。
Neoplasia. 2025 Aug 6;68:101215. doi: 10.1016/j.neo.2025.101215.
3
A Study on the Diagnostic and Prognostic Value of Extrachromosomal Circular DNA in Breast Cancer.乳腺癌中染色体外环状DNA的诊断和预后价值研究

本文引用的文献

1
Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs.数千张癌症基因组图谱揭示了不同类别的复杂结构变异。
Cell. 2020 Oct 1;183(1):197-210.e32. doi: 10.1016/j.cell.2020.08.006.
2
Ribbon: intuitive visualization for complex genomic variation. ribbons:直观的可视化复杂基因组变异。
Bioinformatics. 2021 Apr 20;37(3):413-415. doi: 10.1093/bioinformatics/btaa680.
3
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma.染色体外环状 DNA 驱动神经母细胞瘤致癌基因组重塑。
Genes (Basel). 2025 Jul 6;16(7):802. doi: 10.3390/genes16070802.
4
HyenaCircle: a HyenaDNA-based pretrained large language model for long eccDNA prediction.鬣狗圈:一种基于鬣狗DNA的预训练大型语言模型,用于长链染色体外环状DNA预测。
Front Genet. 2025 Jun 26;16:1641162. doi: 10.3389/fgene.2025.1641162. eCollection 2025.
5
Extrachromosomal DNA: shaping the evolutionary dynamics of cancer.染色体外DNA:塑造癌症的进化动力学
Trends Cancer. 2025 Jul 9. doi: 10.1016/j.trecan.2025.06.004.
6
Epigenetic modifications and their roles in pediatric brain tumor formation: emerging insights from chromatin dysregulation.表观遗传修饰及其在儿童脑肿瘤形成中的作用:染色质失调的新见解
Front Oncol. 2025 Jun 17;15:1569548. doi: 10.3389/fonc.2025.1569548. eCollection 2025.
7
Structural variants in the 3D genome as drivers of disease.三维基因组中的结构变异作为疾病的驱动因素。
Nat Rev Genet. 2025 Jun 30. doi: 10.1038/s41576-025-00862-x.
8
Extrachromosomal circular DNA drives dynamic genome plasticity: emerging roles in disease progression and clinical potential.染色体外环状DNA驱动动态基因组可塑性:在疾病进展中的新作用及临床潜力
Theranostics. 2025 May 25;15(13):6387-6411. doi: 10.7150/thno.111765. eCollection 2025.
9
Extrachromosomal DNA as a carrier of extra copies of oncogenes for heterogeneity and malignancy of glioma.作为癌基因额外拷贝载体的染色体外DNA与胶质瘤的异质性和恶性程度
Acta Pharm Sin B. 2025 May;15(5):2791-2794. doi: 10.1016/j.apsb.2025.02.001. Epub 2025 Feb 3.
10
Selective targeting of genome amplifications and repeat elements by CRISPR-Cas9 nickases to promote cancer cell death.利用CRISPR-Cas9切口酶对基因组扩增和重复元件进行选择性靶向以促进癌细胞死亡。
Nat Commun. 2025 Jun 2;16(1):5126. doi: 10.1038/s41467-025-60160-2.
Nat Genet. 2020 Jan;52(1):29-34. doi: 10.1038/s41588-019-0547-z. Epub 2019 Dec 16.
4
ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.ASCL1 是肾上腺素能神经母细胞瘤核心调控回路中依赖 MYCN 和 LMO1 的成员。
Nat Commun. 2019 Dec 9;10(1):5622. doi: 10.1038/s41467-019-13515-5.
5
Functional Enhancers Shape Extrachromosomal Oncogene Amplifications.功能增强子塑造染色体外致癌基因扩增。
Cell. 2019 Nov 27;179(6):1330-1341.e13. doi: 10.1016/j.cell.2019.10.039. Epub 2019 Nov 21.
6
Circular ecDNA promotes accessible chromatin and high oncogene expression.环状 ecDNA 促进染色质可及性和高致癌基因表达。
Nature. 2019 Nov;575(7784):699-703. doi: 10.1038/s41586-019-1763-5. Epub 2019 Nov 20.
7
JASPAR 2020: update of the open-access database of transcription factor binding profiles.JASPAR 2020:转录因子结合谱开放获取数据库的更新。
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92. doi: 10.1093/nar/gkz1001.
8
Functional dissection of the Sox9-Kcnj2 locus identifies nonessential and instructive roles of TAD architecture.功能剖析 Sox9-Kcnj2 基因座揭示了 TAD 结构的非必要和指导作用。
Nat Genet. 2019 Aug;51(8):1263-1271. doi: 10.1038/s41588-019-0466-z. Epub 2019 Jul 29.
9
The ENCODE Blacklist: Identification of Problematic Regions of the Genome.ENCODE 黑名单:基因组中问题区域的鉴定。
Sci Rep. 2019 Jun 27;9(1):9354. doi: 10.1038/s41598-019-45839-z.
10
Regulatory Landscaping: How Enhancer-Promoter Communication Is Sculpted in 3D.调控景观:增强子-启动子通讯如何在 3D 中被塑造。
Mol Cell. 2019 Jun 20;74(6):1110-1122. doi: 10.1016/j.molcel.2019.05.032.